Author Question: A primary care NP provides teaching to a patient who will begin taking cefadroxil (Duricef). Which ... (Read 59 times)

jc611 · **on:** Jul 24, 2018

A primary care NP provides teaching to a patient who will begin taking cefadroxil (Duricef). Which statement by the patient indicates a need for further teaching?

a. I should report any rash that occurs.
b. I will take this medication twice daily.
c. I should take this medication with food.
d. Gastrointestinal (GI) symptoms are common but not worrisome.

Question 2

A patient who is taking phenytoin (Dilantin) for a newly diagnosed seizure disorder calls the primary care NP to report a rash. The NP should:

a. order a phenytoin level.
b. reassure the patient that this is a self-limiting adverse effect.
c. recommend that the patient take diphenhydramine to treat this side effect.
d. tell the patient to stop taking the phenytoin and contact the neurologist immediately.

asdfghjkl; · **Reply #1 on:** Jul 24, 2018

Answer to Question 1

D
The FDA advises that CDAD be considered in all patients who present with diarrhea after antibiotic use. Patients should be taught to report all GI symptoms.

Answer to Question 2

D
Phenytoin should be discontinued if skin rash appears because some rashes can be life-threatening. Rashes are not related to serum drug levels, so a phenytoin level is not indicated. Although some rashes are self-limiting, the patient should stop taking the drug until serious rashes are ruled out. Suggesting diphenhydramine is not correct until the severity of the rash is known.